After the late Rep. Elijah Cummings launched a drug pricing probe of some of the industry’s largest players last January, six pharmaceutical execs are set to head to Washington next week for hearings at the House Committee on Oversight and Reform. Current and former executives from Celgene, Bristol Myers Squibb, Teva, Amgen, Mallinckrodt and Novartis will testify next Wednesday… Read More »
Dec. 13, 2019 — A U.S. House Democrat bill that would give Medicare the authority to negotiate prescription drug prices and provide new benefits for seniors was passed Thursday in a 230-192 vote along party lines. However, the bill has no chance of being passed by the Republican-controlled Senate and the White House has threatened… Read More »
Speaker of the House Nancy Pelosi, December 10, 2019. Saul Loeb | AFP | Getty Images The House of Representatives on Thursday passed Speaker Nancy Pelosi‘s drug pricing legislation, a sweeping bill that will allow the U.S. government to negotiate lower prices on the costliest drugs each year. The legislation, which passed the House 230… Read More »